Deans' stroke musings: Silicon neuromodulating implant has potential to treat Parkinson’s disease

Changing stroke rehab and research worldwide now.Time is Brain! trillions and trillions of neurons that DIE each day because there are NO effective hyperacute therapies besides tPA(only 12% effective). I have 523 posts on hyperacute therapy, enough for researchers to spend decades proving them out. These are my personal ideas and blog on stroke rehabilitation and stroke research. Do not attempt any of these without checking with your medical provider. Unless you join me in agitating, when you need these therapies they won't be there.

What this blog is for:

My blog is not to help survivors recover, it is to have the 10 million yearly stroke survivors light fires underneath their doctors, stroke hospitals and stroke researchers to get stroke solved. 100% recovery. The stroke medical world is completely failing at that goal, they don't even have it as a goal. Shortly after getting out of the hospital and getting NO information on the process or protocols of stroke rehabilitation and recovery I started searching on the internet and found that no other survivor received useful information. This is an attempt to cover all stroke rehabilitation information that should be readily available to survivors so they can talk with informed knowledge to their medical staff. It lays out what needs to be done to get stroke survivors closer to 100% recovery. It's quite disgusting that this information is not available from every stroke association and doctors group.

Wednesday, August 10, 2022

Silicon neuromodulating implant has potential to treat Parkinson’s disease

And why not for stroke? Well because there are not enough functioning neurons in stroke leadership to see the possible application of this.

Silicon neuromodulating implant has potential to treat Parkinson’s disease

A flexible, implantable electronic device may have clinical application in the treatment of spinal cord injuries and Parkinson’s disease, researchers reported in Proceedings of the National Academy of Sciences.

Tuan-Khoa Nguyen, PhD, a postdoctoral research fellow at Griffith University in Australia, and colleagues used silicon carbide technology as a new platform for long-term electronic bio-tissue interfaces.

“Implantable and flexible devices have enormous potential to treat chronic diseases such as Parkinson’s disease and injuries to the spinal cord,” Nguyen said in a university release. “These devices allow for direct diagnosis of disorders in internal organs and provide suitable therapies and treatments. For instance, such devices can offer electrical stimulations to targeted nerves to regulate abnormal impulses and restore body functions.”

The Griffith University’s Queensland Micro and Nanotechnology Center (QMNC) offers resources for the development and characterization of wide band gap materials, a class of semiconductors that have electronic properties between non-conducting materials, such as glass.

Because these implantable devices will require direct contact with biofluids, the development of functional material that can withstand long-term operation was key.

“The system consists of silicon carbide nanomembranes as the contact surface and silicon dioxide as the protective encapsulation, showing unrivaled stability and maintaining its functionality in biofluids,” Nam-Trung Nguyen, PhD, professor and director of QMNC, said in the release. “For the first time, our team has successfully developed a robust implantable electronic system with an expected duration of a few decades.”

Reference:

Ultra-thin but tough implantable material could treat spinal cord injury and Parkinson’s disease. https://www.eurekalert.org/news-releases/961389. Published Aug. 10, 2022. Accessed Aug. 10, 2022.